Could tougher regulations in Europe now lead to a change of heart in France?
This article was originally published in Clinica
One of the originators of the French healthcare product safety bill has told Clinica that he may be persuaded to propose dropping the provision which would require a three-month notification procedure for medical devices during the second reading of the bill in the Senate. But he will only do so if he is convinced that there are now sufficient guarantees to ensure the safety of high-risk devices.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.